Tag: Infections
Zimmer Biomet India launches bone cements by Teknimed
Tekcem® offers several key advantages, including the incorporation of gentamicin (1G) for superior bacterial defense, ensuring better efficiency against infections
CrisprBits develops PathCrisp for early detection of antibiotic resistance
This new CRISPR-based platform combats antibiotic resistance in hospital-acquired infections by delivering results within two hours, enabling faster and targeted treatment for patients
World AIDS Day: India’s sustained efforts have ensured low HIV epidemic...
Over the years with new infections in the country in 2023 almost 44% lower than in 2010 while AIDS related deaths declined by 79%
Abbott launches 14 valent Pneumococcal Conjugate Vaccine for broader protection against...
Pneumococcal vaccines help address pneumococcal bacterial infections, including pneumonia and meningitis, for which children under two years of age are most at risk
India gets its first indigenous antibiotic ‘Nafithromycin’ to combat drug resistance
New antibiotic offers 10x efficacy with just 3 doses to combat drug-resistant pneumonia
GARDP and Bugworks join forces to accelerate development of a novel...
The compound being developed by Bugworks, BWC0977, is aimed at treating patients with serious bacterial infections in both critical care and community settings
Biotech startup CrisprBits raises 250,000 USD in pre-seed round from US-based...
The company plans to extend its CRISPR-based diagnostics platform to point-of-care detection of pathogens and antimicrobial resistance genes associated with hospital-acquired infections
#IPledgeRED initiative from Roche Diagnostics and Apollo Hospitals puts the spotlight...
Initiative highlights the need for Nucleic Acid Testing (NAT) to screen for underlying infections and reduce the risk of transfusion-transmitted diseases
IIT Jodhpur researchers decode virulence of Klebsiella pneumoniae infections in hospitals
This study will enable the development of methodologies to effectively control the spread of such strains and to treat infections caused by them
Novo Nordisk India launches world’s only peptide in a pill for...
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time